Expression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negative HNSCC

NCT03953443 · clinicaltrials.gov ↗

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

OTHER: Not interventional

Sponsor

New Mexico Cancer Research Alliance